Molina Healthcare stock sets October 21 earnings date

Published on 10/01/2026 at 05:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Molina Healthcare stock posted adjusted Q2 2026 EPS of USD 1.51 versus USD 1.39 consensus. The Q3 report is scheduled for October 21, 2026, after the market close.

Moderner Klinikcampus mit Glasfassade und Gesundheitspersonal vor Skyline — Fotorealistisches Bild zeigt Molina Healthcare US60855R1005 als modernen Klinikcampus mit Personal und Skyline im Hintergrund, Illustration mit AI erstellt.

Molina Healthcare stock (ISIN US6093511094) enters October with adjusted second quarter 2026 diluted EPS of USD 1.51 versus USD 1.39 consensus. The company has scheduled its third quarter report for October 21, 2026, giving investors a defined earnings checkpoint.

Third quarter date is set

According to Business Wire on September 2, 2026, Molina Healthcare will publish its third quarter earnings release after the market close on October 21, 2026. The company plans to discuss the results during a conference call on October 22, 2026, at 8:00 a.m. EDT.

The report will cover the three months ending September 30, 2026. That period matters because Molina's second quarter showed a wide gap between GAAP and adjusted profitability, with GAAP diluted EPS at USD 1.19 and adjusted diluted EPS at USD 1.51.

Revenue remains the key comparison

Molina Healthcare reported second quarter total revenue of USD 10.87 billion, down 4.8 percent from USD 11.43 billion in the same quarter of 2025, according to Business Wire. The adjusted EPS comparison was more favorable than the revenue trend because the USD 1.51 result exceeded the USD 1.39 consensus estimate by USD 0.12.

The next release will show whether the company can improve profitability while managing its government-sponsored health insurance business. Molina serves Medicaid, Medicare and Affordable Care Act Marketplace members, making premium revenue and medical-cost trends central figures for the next report.

Analyst consensus stays cautious

MarketBeat reported on September 20, 2026, that analysts held a consensus rating of Hold with an average 12-month price target of USD 202.44. The tally included three Buy ratings, twelve Hold ratings and two Sell ratings.

That split gives the October report a clear test: revenue was USD 10.87 billion in the second quarter, while adjusted EPS beat consensus by USD 0.12. For investors, the next update will show whether that earnings advantage can offset the year-over-year revenue decline.

Key figures set the next checkpoint

Molina Healthcare's market capitalization was USD 9.9 billion as of September 30, 2026. Its 52-week range was USD 121.06 to USD 244.89 on the same date, placing the October earnings release ahead of a material valuation and profitability checkpoint rather than a routine calendar event.